Company Data
Cadrenal Therapeutics Inc.
Ticker
CVKD
Current Price
$0.5 8.7%
Market Cap
$6.5M
Price Target
Refer to Report
Volume
17.4K
52wk Range
$0.395 - $6.75
Overview
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.